Medical Device CRM: Why Reps Log the Deal and Lose the Case
A medical device CRM must model surgeons, hospital committees, cases, and compliance inputs. See what to require and how to measure your own rep numbers.
Picture a spine surgeon who wants your new system. Six weeks later, nothing has shipped.
They stopped you outside the OR after a case and asked to try it next month. You walked to the car with a commitment and a forecast. The surgeon still wants it. Supply chain has never seen a quote. The committee met without it.
Nobody said no. The request just stalled.
That stall is the core lesson in how to sell medical devices to hospitals: a surgeon's yes starts the sale and settles almost nothing. Under one Wisconsin health system's vendor representative policy, product a rep brings into surgery without a purchase order is treated as a donation.
Between a surgeon's request and a purchase order sit five checkpoints: the buyer, the committee, the contract, the badge, and the compliance record. Here's how to walk a request through all five, and how to check whether your week goes to the right ones.
Checkpoint one is the buyer, and it starts the moment a physician says "I want to try it."
Industry ethics rules from AdvaMed say reps belong in the clinical setting only when a clinician asks for them and supervises. Hospital policies turn that into rules. That policy bars drop-ins and cold calls, says reps must not use the operating room for sales calls, and limits rep support during procedures to observation and verbal consultation.
Now the clause most reps skim past. When a surgeon contacts a rep about a product for surgery, the rep has to present it to the surgery buyer with list and discounted pricing, and the hospital states it will not pay list price.
So the surgeon's enthusiasm has a shelf life. If supply chain hears about your product from the OR before they hear it from you, you've lost control of the price conversation. Make it a habit: when a physician asks for your product, call the buyer the same day with pricing ready.
Clinics and physician groups follow a gentler version of the same rule. A busy physician may give you ten minutes a quarter, so win the practice manager and front-desk staff first. They know the schedule, the complaints, and which week the doctor can spare time. If clinics make up much of your list, prospecting smaller accounts runs on a different rhythm than hospital selling.
Checkpoint two is the value analysis committee (VAC), where a surgeon's request meets the hospital's budget.
A 2024 journal column by a surgeon who co-chaired Northwestern Medicine's orthopaedic VAC lays out how these committees run. They're split by specialty. Clinicians, supply chain staff, and administrators sit at the table, and finance or data analysts sometimes join.
Two details from that column should change how you prep.
First, the surgeon requesting your product is expected to work with supply chain to identify equivalent products already on the market for cost comparison. Your competitor's device will be in the packet whether you put it there or not. Plan for it.
Second, the committee may require that a new product replace an existing one to protect contract pricing and supply chain efficiency. Asking to be added to the shelf is weaker than naming the SKU you replace and what changes when you do.
The author also writes that surgeon preferences have to give way to value, defined as quality divided by cost, and that a time-limited product trial is an option when value is uncertain. That's your opening. Build the packet before the committee builds it for you:
Your surgeon champion carries this into a meeting you may not attend. Give it to them in a form they can present in five minutes, and they'll defend it instead of apologizing for it. For evidence and objection-handling tactics beyond the packet, see this medical device sales strategy breakdown.
Item five deserves its own section, because that price was set before you showed up.
Checkpoint three is the contract. Many hospitals buy through group purchasing organizations, and federal rules shape what that relationship can look like.
Vendors can pay a GPO administrative fees without breaking the anti-kickback law only under set conditions. The fee is 3% or less of the purchase price, or the agreement specifies the amount, and the GPO must disclose to each provider, at least once a year, what it received from each vendor.
That second condition matters more than it looks. The hospital can see what its GPO collected on your products, so your pricing is less private than it feels. And the price conversation usually starts at a contract tier negotiated long before you arrived.
Selling medical devices to hospitals without knowing that tier is guesswork. Before a pitch, ask materials management which GPO contract covers the category. Then ask whether your product is on it, at what tier, and whether the category is up for standardization this year.
Your own company may already hold the answers. McKinsey notes that medtech firms have access to data from group purchasing organizations and integrated delivery networks that can guide where reps spend time. Ask sales ops to put contract status next to each account in your territory plan, so you stop pitching accounts where the category is locked until the next bid.
Checkpoint four is the badge. You can't sell in a hospital you can't enter, so any plan for how to sell medical devices into a health system needs a credentialing line.
AdvaMed puts the U.S. health system's total cost of supplier credentialing at over $1 billion a year, driven by requirements that vary by facility and little reciprocity between them. A national credentialing standard exists. Each facility still sets its own list.
That policy's list shows what to expect: photo ID, proof of training and competencies, immunization records, background checks, and conflict-of-interest forms, plus a vendor badge worn above the waist. Reps who support procedures also need TB testing, vaccination proof, and training on infection control and patient rights, according to the same policy.
Then there's the enforcement section. Under that policy, a second infraction can bring suspension for up to three months, while another rep from your company handles current business.
Translation: a lapsed badge can hand your account to a colleague.
Managers should track credential expiry by facility the way they track contract renewals. Check with compliance before your company offers to pay a cost the hospital would normally carry, too. In 2025 the HHS Office of Inspector General issued an unfavorable advisory opinion on a device maker's plan to pay about $395 per rep for licenses to a hospital bill-only portal.
Checkpoint five is the record you leave behind. Your compliance team owns these rules, and the medical device CRM piece covers Sunshine Act logging in detail. Two facts are worth carrying in your head.
First, the coffee is public. Device makers whose products need FDA premarket approval or notification can qualify as applicable manufacturers under Open Payments, and the payments and transfers of value they report to CMS become publicly available. Small items add up, too: below a single-payment threshold they still get reported once a recipient's annual total crosses the aggregate line.
Second, the stakes are criminal. The Anti-Kickback Statute is a criminal law, and according to the OIG, remuneration includes anything of value, meals and hotel stays included, when offered to induce federally paid business.
How many hospital touches should a device rep make in a day? There's no published, device-specific benchmark we could verify. Implant reps covering cases and capital reps running committee cycles live different days, so a blended average would mislead you anyway.
What does exist is evidence on channel mix. In a McKinsey survey of medtech customers from August 2021, 89% of procurement professionals and 81% of physicians said they prefer more than one channel. The same article reports hospital procurement staff frustrated that reps show up only to make a sale.
That frustration points at checkpoints one and three. So measure your own motion for four weeks:
Weight the log to what you sell. Capital sellers will see more committee and finance rows; implant reps, more case coverage and in-service. Either way, an empty supply chain row is the warning sign.
Go back to the spine surgeon in the hallway. That request stalls at checkpoint one if the buyer hears about it from the OR first. It stalls at two if nobody builds the swap. At three it waits for a contract you never asked about, at four for a badge that lapsed, and at five it can follow your company into a public database.
If you're working out how to sell to hospitals, start with one open opportunity. Call materials management, ask which contract covers the category, and build the five-part committee packet with your surgeon. Then check every credential that expires this quarter.
Every one of those fixes depends on details you pick up in hallways: the size the surgeon mentioned, the buyer's contract question, the nurse who wants an in-service. Most of them surface after a case, when you're in scrubs with no time to type. If that's where your notes go missing, Leadbeam's Pulse turns a spoken note into CRM fields, so the swap, the equivalents, and the buyer's questions are waiting when the committee date lands.
Leadbeam Blog
Discover tips, strategies, and success stories to empower your field sales team and drive results.
